Recombinant multi-species GREM1/Gremlin-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GREM1/Gremlin-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct binding to BMP proteins. As an antagonist of BMP, this gene may play a role in regulating organogenesis, body patterning, and tissue differentiation. In mouse, this protein has been shown to relay the sonic hedgehog (SHH) signal from the polarizing region to the apical ectodermal ridge during limb bud outgrowth. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
The Alternative Names of target: BMP antagonist 1,C15DUPq,CKTSF1B1,CRAC1,CRCS4,Cell proliferation-inducing gene 2 protein,Cktsf1b1,Cysteine knot superfamily 1,DAN domain family member 2,DAND2,DRM,DUP15q,Down-regulated in Mos-transformed cells protein,Drm,GREM1,GREMLIN,Grem,Grem1,Gremlin-1,HMPS,HMPS1,IHG-2,Increased in high glucose protein 2 (IHG-2),MPSH,PIG2,drm,gremlin-1,ld
Go
to GREM1/Gremlin-1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T22104-Ag-1/ GM-Tg-hg-T22104-Ag-2 | Human GREM1/Gremlin-1 protein | Human |
GM-Tg-rg-T22104-Ag-1/ GM-Tg-rg-T22104-Ag-2 | Rat GREM1/Gremlin-1 protein | Rat |
GM-Tg-mg-T22104-Ag-1/ GM-Tg-mg-T22104-Ag-2 | Mouse GREM1/Gremlin-1 protein | Mouse |
GM-Tg-cynog-T22104-Ag-1/ GM-Tg-cynog-T22104-Ag-2 | Cynomolgus/Rhesus macaque GREM1/Gremlin-1 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T22104-Ag-1/ GM-Tg-felg-T22104-Ag-2 | Feline GREM1/Gremlin-1 protein | Feline |
GM-Tg-cang-T22104-Ag-1/ GM-Tg-cang-T22104-Ag-2 | Canine GREM1/Gremlin-1 protein | Canine |
GM-Tg-bovg-T22104-Ag-1/ GM-Tg-bovg-T22104-Ag-2 | Bovine GREM1/Gremlin-1 protein | Bovine |
GM-Tg-equg-T22104-Ag-1/ GM-Tg-equg-T22104-Ag-2 | Equine GREM1/Gremlin-1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T22104-Ag-1/ GM-Tg-hg-T22104-Ag-2;
GM-Tg-rg-T22104-Ag-1/ GM-Tg-rg-T22104-Ag-2;
GM-Tg-mg-T22104-Ag-1/ GM-Tg-mg-T22104-Ag-2; GM-Tg-cynog-T22104-Ag-1/ GM-Tg-cynog-T22104-Ag-2; GM-Tg-felg-T22104-Ag-1/ GM-Tg-felg-T22104-Ag-2; GM-Tg-cang-T22104-Ag-1/ GM-Tg-cang-T22104-Ag-2; GM-Tg-bovg-T22104-Ag-1/ GM-Tg-bovg-T22104-Ag-2; GM-Tg-equg-T22104-Ag-1/ GM-Tg-equg-T22104-Ag-2 |
Products Name | GREM1/Gremlin-1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | GREM1/Gremlin-1 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GREM1/Gremlin-1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.